Yunxiang Xu

Yunxiang represents companies, investment banks and private equity funds in IPOs and other corporate transactions.

Prior to joining Cooley, Yunxiang had worked at the Beijing office of a leading US law firm.

Yunxiang is a native Mandarin speaker and is fluent in English.

Representative Matters:

Capital Markets

• Represented underwriters in Insilico Medicine’s HK$2.277 billion IPO and listing on the HKEX (the largest biotech HK IPO in 2025)
• Represented Shanghai Bao Pharmaceuticals in its HK$1 billion IPO and listing on the HKEX
• Represented PATEO in its HK$1.07 billion IPO and listing on the HKEX
• Represented Innogen Pharmaceuticals in its HK$683 million IPO and listing on the HKEX
• Represented Leads Biolabs in its HK$1.29 billion IPO and listing on the HKEX
• Represented underwriters in Duality Biotherapeutics’ HK$1.64 billion IPO and listing on the HKEX
• Represented ImmuneOnco in its HK$319 million IPO and listing on the HKEX
• Represented underwriters in Cryofocus Medtech's HK$210 million IPO and listing on HKEX
• Represented underwriters in Beike’s US$2.1 billion IPO and listing on the NYSE
• Represented Pop Mart in its US$674 million IPO and listing on the HKEX
• Represented Kingsoft Cloud in its US$510 million IPO and listing on the Nasdaq
• Represented underwriters in Remegen’s US$515 million IPO and listing on the HKEX
• Represented underwriters in iQIYI’s $US2.25 billion IPO and listing on the Nasdaq
• Represented DouYu in its US$775 million IPO and listing on the Nasdaq
• Represented Liepin in its US$353 million IPO and listing on the HKEX
• Represented underwrites in BeiGene’s US$903 million IPO and listing on the HKEX
• Represented underwriters in Asiainfo’s US$115 million IPO and listing on the HKEX
• Represented underwriters in Mogu’s $US66.5 million IPO and listing on the NYSE
• Represented CNOOC in its US$3.8 billion SEC-registered notes offering

M&A and Private Equity

• Represented Asymchem in its agreement to acquire Snapdragon Chemistry, Inc., a US-based chemical technology company
• Represented a neutral internet data center service provider on the private placement of convertible notes to Blackstone Group
• Represented a 3D interior design, decoration, and construction software platform in completing a growth equity financing led by Hillhouse Investment
• Represented IDG Capital in its secondary sale of interests in various investments funds
• Represented IDG Capital as a lead member of a consortium in a tender offer to purchase all the outstanding shares of a US listed company
• Represented Warburg Pincus in its sale of joint venture interests in China
• Represented an internet technology company in the residential services sector in the private placement of common stock to several U.S. asset management firms

Public Company Compliance

• Represented CICC (HKEX: 3908), PICC (HKEX: 1339), Douyu (Nasdaq: DOYU), Yiren Digital (NYSE: YRD), and Fangdd (Nasdaq: DUO) in their post-listing compliance matters